milrinone has been researched along with Brain Ischemia in 11 studies
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this article is to provide a systematic review of the evidence supporting the use of milrinone for the management of delayed cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH)." | 8.95 | The Use of Milrinone in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage: A Systematic Review. ( Guichon, C; Lannes, M; Teitelbaum, J; Zeiler, F, 2017) |
| "Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown." | 8.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "The role of nimodipine and milrinone in the management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) was studied using clinical and TCD (transcranial Doppler) parameters." | 8.12 | Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia. ( Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M, 2022) |
| "Intravenous (IV) milrinone is a promising option for the treatment of cerebral vasospasm with delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH)." | 7.96 | Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia. ( Abulhasan, YB; Angle, MR; Ortiz Jimenez, J; Simoneau, G; Teitelbaum, J, 2020) |
| "Milrinone has been identified as a promising therapeutic agent for DCI, possessing a mechanism of action for the reversal of cerebral vasospasm as well as potentially anti-inflammatory effects to treat the underlying etiology of DCI." | 6.72 | Treatment of Subarachnoid Hemorrhage-associated Delayed Cerebral Ischemia With Milrinone: A Review and Proposal. ( Abulhasan, YB; Angle, MR; Aziz-Sultan, MA; Bernier, TD; Chung, DY; Dasenbrock, H; Du, R; Feske, S; Henderson, GV; Izzy, S; Leslie-Mazwi, TM; Nelson, SE; Patel, N; Schontz, MJ, 2021) |
| "Delayed cerebral ischemia (DCI) is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and is associated with significant morbidity and mortality." | 5.91 | Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada. ( Almojuela, A; Bokhari, R; Christie, SD; Duda, T; Eagles, ME; Elkaim, LM; Iorio-Morin, C; Kameda-Smith, MM; Lownie, SP; MacLean, MA; Persad, ARL; Rizzuto, MA; Teitelbaum, J, 2023) |
| "OBJECTIVE Delayed cerebral ischemia (DCI) is an important complication after aneurysmal subarachnoid hemorrhage (aSAH)." | 5.48 | Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Chin, M; Fukuda, H; Handa, A; Koyanagi, M; Kurosaki, Y; Lo, B; Sadamasa, N; Uezato, M; Yamagata, S, 2018) |
| "Acute cerebral hypoperfusion following subarachnoid hemorrhage (SAH) is highly related to the pathogenesis of delayed cerebral ischemia (DCI), but the therapeutic option is poorly available." | 5.46 | Neurocardiac protection with milrinone for restoring acute cerebral hypoperfusion and delayed ischemic injury after experimental subarachnoid hemorrhage. ( Ishikawa, T; Mutoh, T; Nakamura, K; Sasaki, K; Taki, Y; Tatewaki, Y, 2017) |
| "Milrinone treatment significantly decreased cerebral infarct size and reversed I/R-induced impairments in memory and motor coordination." | 5.36 | Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. ( Jaggi, A; Saklani, R; Singh, N, 2010) |
| "The purpose of this article is to provide a systematic review of the evidence supporting the use of milrinone for the management of delayed cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH)." | 4.95 | The Use of Milrinone in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage: A Systematic Review. ( Guichon, C; Lannes, M; Teitelbaum, J; Zeiler, F, 2017) |
| "Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown." | 4.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "The role of nimodipine and milrinone in the management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) was studied using clinical and TCD (transcranial Doppler) parameters." | 4.12 | Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia. ( Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M, 2022) |
| "Intravenous (IV) milrinone is a promising option for the treatment of cerebral vasospasm with delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH)." | 3.96 | Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia. ( Abulhasan, YB; Angle, MR; Ortiz Jimenez, J; Simoneau, G; Teitelbaum, J, 2020) |
| "Milrinone has been identified as a promising therapeutic agent for DCI, possessing a mechanism of action for the reversal of cerebral vasospasm as well as potentially anti-inflammatory effects to treat the underlying etiology of DCI." | 2.72 | Treatment of Subarachnoid Hemorrhage-associated Delayed Cerebral Ischemia With Milrinone: A Review and Proposal. ( Abulhasan, YB; Angle, MR; Aziz-Sultan, MA; Bernier, TD; Chung, DY; Dasenbrock, H; Du, R; Feske, S; Henderson, GV; Izzy, S; Leslie-Mazwi, TM; Nelson, SE; Patel, N; Schontz, MJ, 2021) |
| "Delayed cerebral ischemia (DCI) is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and is associated with significant morbidity and mortality." | 1.91 | Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada. ( Almojuela, A; Bokhari, R; Christie, SD; Duda, T; Eagles, ME; Elkaim, LM; Iorio-Morin, C; Kameda-Smith, MM; Lownie, SP; MacLean, MA; Persad, ARL; Rizzuto, MA; Teitelbaum, J, 2023) |
| "OBJECTIVE Delayed cerebral ischemia (DCI) is an important complication after aneurysmal subarachnoid hemorrhage (aSAH)." | 1.48 | Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Chin, M; Fukuda, H; Handa, A; Koyanagi, M; Kurosaki, Y; Lo, B; Sadamasa, N; Uezato, M; Yamagata, S, 2018) |
| "Acute cerebral hypoperfusion following subarachnoid hemorrhage (SAH) is highly related to the pathogenesis of delayed cerebral ischemia (DCI), but the therapeutic option is poorly available." | 1.46 | Neurocardiac protection with milrinone for restoring acute cerebral hypoperfusion and delayed ischemic injury after experimental subarachnoid hemorrhage. ( Ishikawa, T; Mutoh, T; Nakamura, K; Sasaki, K; Taki, Y; Tatewaki, Y, 2017) |
| "Milrinone treatment significantly decreased cerebral infarct size and reversed I/R-induced impairments in memory and motor coordination." | 1.36 | Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. ( Jaggi, A; Saklani, R; Singh, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Steiger, HJ | 1 |
| Ensner, R | 1 |
| Andereggen, L | 1 |
| Remonda, L | 1 |
| Berberat, J | 1 |
| Marbacher, S | 1 |
| Eagles, ME | 1 |
| MacLean, MA | 1 |
| Kameda-Smith, MM | 1 |
| Duda, T | 1 |
| Persad, ARL | 1 |
| Almojuela, A | 1 |
| Bokhari, R | 1 |
| Iorio-Morin, C | 1 |
| Elkaim, LM | 1 |
| Rizzuto, MA | 1 |
| Lownie, SP | 1 |
| Christie, SD | 1 |
| Teitelbaum, J | 3 |
| Kotwal, A | 1 |
| Ramalingaiah, AH | 1 |
| Shukla, D | 1 |
| Radhakrishnan, M | 1 |
| Konar, SK | 1 |
| Srinivasaiah, B | 1 |
| Chakrabarti, D | 1 |
| Sundaram, M | 1 |
| Abulhasan, YB | 2 |
| Ortiz Jimenez, J | 1 |
| Simoneau, G | 1 |
| Angle, MR | 2 |
| Bernier, TD | 1 |
| Schontz, MJ | 1 |
| Izzy, S | 1 |
| Chung, DY | 1 |
| Nelson, SE | 1 |
| Leslie-Mazwi, TM | 1 |
| Henderson, GV | 1 |
| Dasenbrock, H | 1 |
| Patel, N | 1 |
| Aziz-Sultan, MA | 1 |
| Feske, S | 1 |
| Du, R | 1 |
| Castle-Kirszbaum, M | 1 |
| Lai, L | 1 |
| Maingard, J | 1 |
| Asadi, H | 1 |
| Danks, RA | 1 |
| Goldschlager, T | 1 |
| Chandra, RV | 1 |
| Lannes, M | 1 |
| Zeiler, F | 1 |
| Guichon, C | 1 |
| Mutoh, T | 4 |
| Nakamura, K | 2 |
| Yamamoto, Y | 1 |
| Tsuru, Y | 1 |
| Tsubone, H | 1 |
| Ishikawa, T | 2 |
| Taki, Y | 2 |
| Sasaki, K | 1 |
| Tatewaki, Y | 1 |
| Koyanagi, M | 1 |
| Fukuda, H | 1 |
| Lo, B | 1 |
| Uezato, M | 1 |
| Kurosaki, Y | 1 |
| Sadamasa, N | 1 |
| Handa, A | 1 |
| Chin, M | 1 |
| Yamagata, S | 1 |
| Saklani, R | 1 |
| Jaggi, A | 1 |
| Singh, N | 1 |
3 reviews available for milrinone and Brain Ischemia
| Article | Year |
|---|---|
Treatment of Subarachnoid Hemorrhage-associated Delayed Cerebral Ischemia With Milrinone: A Review and Proposal.
Topics: Brain Ischemia; Humans; Milrinone; Multicenter Studies as Topic; Randomized Controlled Trials as Top | 2021 |
Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review.
Topics: Brain Ischemia; Cerebral Infarction; Female; Humans; Male; Middle Aged; Milrinone; Pharmaceutical Pr | 2021 |
The Use of Milrinone in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage: A Systematic Review.
Topics: Brain Ischemia; Humans; Milrinone; Subarachnoid Hemorrhage; Vasodilator Agents | 2017 |
8 other studies available for milrinone and Brain Ischemia
| Article | Year |
|---|---|
Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Hemodynamics; Humans; Hypertension; Milrinone; Nimodipine; Nore | 2022 |
Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada.
Topics: Brain Ischemia; Canada; Cerebral Infarction; Cross-Sectional Studies; Humans; Milrinone; Subarachnoi | 2023 |
Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia.
Topics: Brain Ischemia; Cerebral Infarction; Humans; Milrinone; Nimodipine; Subarachnoid Hemorrhage; Vasospa | 2022 |
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia.
Topics: Adult; Aged; Angioplasty; Brain Ischemia; Cohort Studies; Female; Follow-Up Studies; Humans; Injecti | 2020 |
Acute cardiac support with intravenous milrinone promotes recovery from early brain injury in a murine model of severe subarachnoid haemorrhage.
Topics: Administration, Intravenous; Animals; Brain Injuries; Brain Ischemia; Cerebrovascular Circulation; D | 2017 |
Neurocardiac protection with milrinone for restoring acute cerebral hypoperfusion and delayed ischemic injury after experimental subarachnoid hemorrhage.
Topics: Animals; Brain Ischemia; Cardiotonic Agents; Cerebral Cortex; Echocardiography, Doppler; Heart; Male | 2017 |
Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Aged; Brain Ischemia; Catheters; Female; Humans; Injections, Spinal; Male; Middle Aged; Milrinone; S | 2018 |
Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice.
Topics: Animals; Brain Ischemia; Ischemic Preconditioning; Male; Maze Learning; Memory Disorders; Mice; Milr | 2010 |